Online Broker

Kensington Capital Acquisition Corp. V Announces Pricing of Upsized $240,000,000 Initial Public Offering Kensington Capital Acquisition Corp. V Announces Pricing of Upsized $240,000,000 Initial Public Offering

PR Newswire

WESTBURY, N.Y., Aug. 12, 2021

WESTBURY, N.Y., Aug. 12, 2021 /PRNewswire/ -- Kensington Capital Acquisition Corp. V (the "Company"), today announced the pricing of its initial public offering of 24,000,000 units at a price of $10.00 per unit. The Company is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any industry or sector, it intends to focus its search on companies in the North American and European industrials sector. The Company is led by Chairman and Chief Executive Officer, Justin Mirro, Vice Chairman and President, John Arney, Chief Financial Officer, Daniel Huber, Chief Technology Officer, Dr. Peter Goode, and Head of Business Development, Julian Ameler. The Company's independent directors include Anders Pettersson, Mitchell Quain, Mark Robertshaw, Nickolas Vande Steeg and William E. Kassling.

The units will be listed on the New York Stock Exchange and trade under the ticker symbol "KCGI.U" beginning August 13, 2021. Each unit consists of one Class A ordinary share of the Company and three-fourths of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on the New York Stock Exchange under the symbols "KCGI" and "KCGI.WS," respectively.

The offering is expected to close on August 17, 2021, subject to customary closing conditions.

UBS Securities LLC and Stifel, Nicolaus & Company, Incorporated are acting as the joint book running managers for the offering, Robert W. Baird & Co. Incorporated is acting as lead manager and Drexel Hamilton, LLC and EarlyBirdCapital, Inc. are acting as co-managers. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,600,000 units at the initial public offering price to cover over-allotments, if any.

The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from UBS Securities LLC, Attn: Prospectus Department, 1285 Avenue of the Americas, New York, NY 10019, telephone: (888) 827-7275 or email: ol-prospectusrequest@ubs.com; and Stifel, Nicolaus & Company, Incorporated, Attn: Syndicate Department, One South Street, 15th Floor, Baltimore, MD 21202, or by email: SyndProspectus@Stifel.com or by telephone: (855) 300-7136.

Registration statements relating to the securities became effective on August 12, 2021 in accordance with the Securities Act of 1933, as amended. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms or timeline described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statements and preliminary prospectus for the Company's offering filed with the Securities and Exchange Commission ("SEC"). Copies of these documents are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact:Daniel HuberChief Financial Officerdan@kensington-cap.com (703) 674-6514

View original content to download multimedia:https://www.prnewswire.com/news-releases/kensington-capital-acquisition-corp-v-announces-pricing-of-upsized-240-000-000-initial-public-offering-301354862.html

SOURCE Kensington Capital Acquisition Corp. V

Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals Other fully vaccinated individuals do not need an additional vaccine dose right now

PR Newswire

SILVER SPRING, Md., Aug. 12, 2021

SILVER SPRING, Md., Aug. 12, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals, specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise. The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices is scheduled to meet Friday to discuss further clinical recommendations regarding immunocompromised individuals. Today's action does not apply to people who are not immunocompromised.

"The country has entered yet another wave of the COVID-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease. After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna Vaccines," said Acting FDA Commissioner Janet Woodcock, M.D. "Today's action allows doctors to boost immunity in certain immunocompromised individuals who need extra protection from COVID-19. As we've previously stated, other individuals who are fully vaccinated are adequately protected and do not need an additional dose of COVID-19 vaccine at this time. The FDA is actively engaged in a science-based, rigorous process with our federal partners to consider whether an additional dose may be needed in the future."

People who are immunocompromised in a manner similar to those who have undergone solid organ transplantation have a reduced ability to fight infections and other diseases, and they are especially vulnerable to infections, including COVID-19. The FDA evaluated information on the use of a third dose of the Pfizer-BioNTech or Moderna Vaccines in these individuals and determined that the administration of third vaccine doses may increase protection in this population. These patients should be counseled to maintain physical precautions to help prevent COVID-19. In addition, close contacts of immunocompromised persons should get vaccinated, as appropriate for their health status, to provide increased protection to their loved ones.

It is recommended that immunocompromised individuals discuss monoclonal antibody treatment options with their health care provider should they contract or be exposed to COVID-19. The FDA has authorized monoclonal antibody treatments for emergency use during this public health emergency for adults and pediatric patients (ages 12 and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progressing to severe COVID-19 and/or hospitalization. One authorized product includes use for preventative (prophylaxis) treatment after being exposed to SARS-CoV-2; however, this product is not a substitute for vaccination. 

The Pfizer-BioNTech COVID-19 Vaccine is currently authorized for emergency use in individuals ages 12 and older, and the Moderna COVID-19 Vaccine is authorized for emergency use in individuals ages 18 and older. Both vaccines are administered as a series of two shots: the Pfizer-BioNTech COVID-19 Vaccine is administered three weeks apart, and the Moderna COVID-19 Vaccine is administered one month apart. The authorizations for these vaccines have been amended to allow for an additional, or third, dose to be administered at least 28 days following the two-dose regimen of the same vaccine to individuals 18 years of age or older (ages 12 or older for Pfizer-BioNTech) who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.

The EUA amendments for the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine were issued to Pfizer Inc. and ModernaTX Inc., respectively.

Additional Resources:

Pfizer-BioNTech COVID-19 Vaccine Moderna COVID-19 Vaccine

Media Contact: FDA Office of Media Affairs, 301-796-4540 Consumer Inquiries: Email or 888-INFO-FDA

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/coronavirus-covid-19-update-fda-authorizes-additional-vaccine-dose-for-certain-immunocompromised-individuals-301354860.html

SOURCE U.S. Food and Drug Administration

Following Is a Test Release Following Is a Test Release

PR Newswire

                          TESTING - TESTING - TESTING                          TESTING - TESTING - TESTING

                          TESTING - TESTING - TESTING                          TESTING - TESTING - TESTING

                          TESTING - TESTING - TESTING                          TESTING - TESTING - TESTING

                          TESTING - TESTING - TESTING                          TESTING - TESTING - TESTING

                          TESTING - TESTING - TESTING                          TESTING - TESTING - TESTING

                          TESTING - TESTING - TESTING                          TESTING - TESTING - TESTING

                          TESTING - TESTING - TESTING                          TESTING - TESTING - TESTING

                          TESTING - TESTING - TESTING                          TESTING - TESTING - TESTING

                          TESTING - TESTING - TESTING                          TESTING - TESTING - TESTING

                          TESTING - TESTING - TESTING                          TESTING - TESTING - TESTING

 

View original content:http://www.prnewswire.com/news-releases/httpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews-releaseshttpwwwprnewswirecomnews--0.html

SOURCE PR Newswire

JDDJ, JD Beauty and Sephora Collaborate to Deliver Cosmetics Products Within One Hour JDDJ, JD Beauty and Sephora Collaborate to Deliver Cosmetics Products Within One Hour

PR Newswire

SHANGHAI, Aug. 12, 2021

SHANGHAI, Aug. 12, 2021 /PRNewswire/ -- Dada Group (Nasdaq: DADA), China's leading local on-demand delivery and retail platform, today announced that JD Daojia (JDDJ) and Sephora China, the world's leading beauty retailer under LVMH, have established a close partnership to provide more consumers with convenient one-hour shopping services. The move marks a new milestone for JDDJ in further expanding reach beyond grocery to provide consumers with more high-quality beauty products.

When consumers order via the JDDJ application or mini program, beauty products are delivered from the nearest Sephora store within one hour by Dada Now's riders. As of now, over 70 Sephora stores in China have launched on the JDDJ platform, covering first and second tier cities.

Based on Dada Group's partnership with JD.com, these Sephora stores will be simultaneously online with JD.com. By the end of 2021, all Sephora stores in China will be integrated both on JDDJ and JD.com.

Moreover, JDDJ collaborates with JD Beauty to support Sephora in its omni-channel retail, and to jointly build a new on-demand retail model of cosmetics brands. JDDJ will assist in products management, digital marketing, targeted user operations, and order fulfillment optimization, and provides an integrated O2O retail solution. With a large base of consumers with strong consumption power, JD Beauty can provide powerful advertising and help the brand reach more consumers.

At present, over 3,400 beauty stores have launched on JDDJ. The platform has also established partnerships with Watsons, Guerlain, Innisfree, THE COLORIST, and WOW COLOUR, creating a high-density and large-scale beauty supply network with beauty brands and chain retailers. During the recent 618 Shopping Festival, China's major mid-year online shopping event from June 1 to 18, sales of beauty products on JDDJ increased by more than double when compared to the same period last year.

About Dada Group

Dada Group is a leading platform of local on-demand retail and delivery in China. It operates JDDJ, one of China's largest local on-demand retail platforms for retailers and brand owners, and Dada Now, a leading local on-demand delivery platform open to merchants and individual senders across various industries and product categories. The company's two platforms are inter-connected and mutually beneficial. The Dada Now platform enables improved delivery experience for participants on the JDDJ platform through its readily accessible fulfillment solutions and strong on-demand delivery infrastructure. Meanwhile, the vast volume of on-demand delivery orders from the JDDJ platform increases order volume and density for the Dada Now platform. In June 2020, Dada Group began trading on the Nasdaq Global Market, under the ticker symbol "DADA."

About Sephora

Sephora is the world's most loved beauty community, offering a unique retail experience for passionate clients and innovative beauty brands, encouraging them to be fearless in their creativity and self-expression. Since its debut in France almost 50 years ago, Sephora has been a leader in global prestige omni-retail, inspiring clients to explore a universe of beauty and wellness with an ever-changing array of carefully curated brand partners, from classic selective brands to exclusive independent ones, and the critically acclaimed Sephora Collection. Owned by LVMH Moët Hennessy Louis Vuitton, the world's leading luxury goods group, Sephora's excellence, innovation, and entrepreneurial spirit have made it an omnichannel beauty trailblazer in 35 countries.

View original content to download multimedia:https://www.prnewswire.com/news-releases/jddj-jd-beauty-and-sephora-collaborate-to-deliver-cosmetics-products-within-one-hour-301354856.html

SOURCE Dada Group

Truffles Market growth analysis in Packaged Foods & Meats Industry | Technavio Truffles Market growth analysis in Packaged Foods & Meats Industry | Technavio

PR Newswire

NEW YORK, Aug. 12, 2021

NEW YORK, Aug. 12, 2021 /PRNewswire/ -- According to Technavio, incremental growth of USD 20.51 million is expected in the truffles market during 2020-2024. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the truffles market in optimistic, probable, and pessimistic forecast scenarios.

Request a Free Sample Report to Know More

Factors such as the health benefits of truffles and the launch of truffle-based products will offer immense growth opportunities. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. The truffles market is fragmented, and the degree of fragmentation will accelerate during the forecast period.

Truffles Market 2020-2024: Segmentation

Truffles Market is segmented as below:

Product Black Truffles White Truffles OthersGeography Europe North America APAC MEA South America

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43639

Truffles Market 2020-2024: Vendor Analysis and Scope

Some of the major vendors of the truffles market in packaged foods and meats industry include Arotz S.A., Conservas Ferrer S.A., Gazzarrini Tartufi, La Maison Plantin, LES FRÈRES JAUMARD, Qingdao Colorful Farm Food Co. Ltd., Sabatino Italia Srl, The Truffle & Wine Co., The Truffles Co., and Urbani Tartufi Srl. To help businesses improve their market position, Technavio's report provides a detailed analysis of around 25 vendors operating in the market.

The report also covers the following areas:

Truffles Market size Truffles Market trends Truffles Market industry analysis

The growth in commercial truffle farming is likely to emerge as one of the primary drivers of the market. However, the fluctuating prices of truffles may threaten the growth of the market.

Register for a free trial today and gain instant access to 17,000+ market research reports.Technavio's SUBSCRIPTION platform

Backed with competitive intelligence and benchmarking, our research report on the truffles market is designed to provide entry support, customer profile & M&As as well as go-to-market strategy support.

Related Reports on Consumer Staples Include:Global Truffle Chocolate Market - Global truffle chocolate market is segmented by product (boxed assortments-based truffle chocolate and seasonal-based truffle chocolate) and geography (APAC, Europe, MEA, North America, and South America).Download Exclusive Free Sample Report

Global White Chocolate Market - Global white chocolate market is segmented by product (white chocolate bars, white chocolate bulk, and white chocolate truffles) and geography (APAC, Europe, MEA, North America, and South America).Download Exclusive Free Sample Report

Truffles Market 2020-2024: Key Highlights

CAGR of the market during the forecast period 2020-2024 Detailed information on factors that will assist truffles market growth during the next five years Estimation of the truffles market size and its contribution to the parent market Predictions on upcoming trends and changes in consumer behavior The growth of the truffles market Analysis of the market's competitive landscape and detailed information on vendors Comprehensive details of factors that will challenge the growth of truffles market vendors

Table of Contents:

Executive Summary

Market Landscape

Market ecosystem Value chain analysis

Market Sizing

Market definition Market segment analysis Market size 2019 Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

Five forces summary Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

Market Segmentation by Product

Market segments Comparison by Product Black truffles - Market size and forecast 2019-2024 White truffles - Market size and forecast 2019-2024 Others - Market size and forecast 2019-2024 Market opportunity by Product

Customer landscape

Overview

Geographic Landscape

Geographic segmentation Geographic comparison Europe - Market size and forecast 2019-2024 North America - Market size and forecast 2019-2024 APAC - Market size and forecast 2019-2024 MEA - Market size and forecast 2019-2024 South America - Market size and forecast 2019-2024 Impact of COVID-19 pandemic on the global market Key leading countries Market opportunity by geography Market drivers Market challenges Market trends

Vendor Landscape

Vendor landscape Landscape disruption

Vendor Analysis

Vendors covered Market positioning of vendors Angellozzi Tartuficoltura Arotz SA Gazzarrini Tartufi La Maison Plantin Les Frères Jaumard Sabatino Italia Srl The Truffle & Wine Co. The Truffles Co. The Welsh Truffle Co. Urbani Tartufi Srl

Appendix

Scope of the report Currency conversion rates for US$ Research methodology List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

ContactTechnavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: media@technavio.comWebsite: www.technavio.com/Report: www.technavio.com/report/truffles-market-industry-analysis

View original content to download multimedia:https://www.prnewswire.com/news-releases/truffles-market-growth-analysis-in-packaged-foods--meats-industry--technavio-301354162.html

SOURCE Technavio